Mirum Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-41.42	-87.94	-163.42	-135.67	-83.99	-103.27
Depreciation & Amortization	25.58	24.98	11.45	3.68	0.6	0.62
Other Amortization	1.72	1.66	1.12	-	-	-
Loss (Gain) From Sale of Assets	-	-	-	-	-108	-
Loss (Gain) From Sale of Investments	-	-	-	-	-0.14	0.07
Stock-Based Compensation	65.65	48.44	35.02	27.01	23.09	12.55
Other Operating Activities	0.56	0.59	64.1	5.89	18.7	0.34
Change in Accounts Receivable	-39.91	-11.43	-43.97	-20.73	-	-
Change in Inventory	-6.38	-3.17	-0.97	-3.45	-0.5	-
Change in Accounts Payable	56	40.31	30.78	7.64	22.66	3.68
Change in Other Net Operating Assets	-17.1	-3.13	-5.05	-4.51	-5.18	-3.07
Operating Cash Flow	44.69	10.33	-70.94	-120.14	-132.76	-89.08
Capital Expenditures	-0.37	-0.99	-0.11	-0.28	-0.02	-0.23
Cash Acquisitions	-	-	-212.76	-	-	-
Sale (Purchase) of Intangibles	-	-20	-20	-	-19	-
Investment in Securities	-23.95	-69.13	125.67	7.98	-40.43	38.1
Other Investing Activities	-	-	-	-	108	-
Investing Cash Flow	-24.32	-90.13	-107.2	7.7	48.55	37.87
Long-Term Debt Issued	-	-	305.3	-	-	-
Total Debt Issued	-	-	305.3	-	-	-
Net Debt Issued (Repaid)	-	-	305.3	-	-	-
Issuance of Common Stock	36.48	17.7	227.15	114.64	9.01	131.87
Other Financing Activities	-	-	-195.86	-5.55	64.45	49.42
Financing Cash Flow	36.48	17.7	336.6	109.09	73.47	181.29
Foreign Exchange Rate Adjustments	2.25	-1.3	-0.13	0.01	-0	0.03
Net Cash Flow	59.11	-63.4	158.32	-3.34	-10.75	130.12
Free Cash Flow	44.32	9.33	-71.05	-120.41	-132.78	-89.3
Free Cash Flow Margin	9.39%	2.77%	-38.12%	-156.26%	-693.81%	-
Free Cash Flow Per Share	0.90	0.20	-1.74	-3.54	-4.38	-3.54
Cash Interest Paid	12.65	12.65	6.82	-	-	-
Cash Income Tax Paid	2.38	1	0.13	-	-	0.01
Levered Free Cash Flow	48.71	18.02	-90.73	-68.13	-96.18	-49.12
Unlevered Free Cash Flow	55.97	25.3	-82.41	-58.14	-85.19	-48.91
Change in Working Capital	-7.39	22.59	-19.22	-21.05	16.98	0.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.